Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 9778245.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
PTEN is a tumor suppressor with sequence homology to protein tyrosine phosphatases and the cytoskeletal protein tensin. mPTEN-mutant mouse embryos display regions of increased proliferation. In contrast, mPTEN-deficient immortalized mouse embryonic fibroblasts exhibit decreased sensitivity to cell death in response to a number of apoptotic stimuli, accompanied by constitutively elevated activity and phosphorylation of protein kinase B/Akt, a crucial regulator of cell survival. Expression of exogenous PTEN in mutant cells restores both their sensitivity to agonist-induced apoptosis and normal pattern of PKB/Akt phosphorylation. Furthermore, PTEN negatively regulates intracellular levels of phosphatidylinositol (3,4,5) trisphosphate in cells and dephosphorylates it in vitro. Our results show that PTEN may exert its role as a tumor suppressor by negatively regulating the PI3'K/PKB/Akt signaling pathway.
Medical subject headings
- Apoptosis
- Genes, Tumor Suppressor
- Phosphoric Monoester Hydrolases
- Protein Serine-Threonine Kinases
- Protein Tyrosine Phosphatases
- Proto-Oncogene Proteins
- Tumor Suppressor Proteins